Avaleht › Kopsuvähk › Massachusetts › Worcester
Kopsuvähk kliinilised uuringud linnas Worcester, MA
11 uuringut haiguse Kopsuvähk jaoks otsivad osalejaid linnas Worcester ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
VärbamineFaas 3
- UMass Memorial Medical Center - University Campus, Worcester
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
VärbamineFaas 3
- Dana-Farber/Brigham and Women's Cancer Center at Milford Regional, Milford · 17 mi kaugusel
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
VärbamineFaas 3
- UMass Memorial Medical Center - University Campus, Worcester
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
VärbamineFaas 3
- UMass Memorial Medical Center - University Campus, Worcester
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
VärbamineFaas 3
- Reliant Medical Group Inc, Worcester
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
VärbamineFaas 3
- University of Massachusetts Memorial Medical Center, Worcester
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
VärbamineFaas 3
- UMass Memorial Medical Center - University Campus, Worcester
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
VärbamineFaas 2
- UMass Memorial Medical Center - University Campus, Worcester
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
VärbamineFaas 2
- UMass Memorial Medical Center - University Campus, Worcester
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
VärbamineFaas 2/3
- UMass Memorial Medical Center - University Campus, Worcester
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
VärbamineVaatlusuuring
- Massive Bio SYNERGY-AI site, Worcester
Kopsuvähk uuringud teistes linnades
- Houston, TX78 uuringut
- Boston, MA62 uuringut
- New York City, NY60 uuringut
- Los Angeles, CA45 uuringut
- Washington, DC41 uuringut
- Arlington, VA41 uuringut
- Chicago, IL41 uuringut
- Nashville, TN40 uuringut
- Baltimore, MD40 uuringut
- St. Louis, MO39 uuringut
- Columbus, OH37 uuringut
- Philadelphia, PA36 uuringut
Muud uuringud linnas Worcester
- Mitteväikerakuline kopsuvähk14 uuringut
- Vähk (kõik liigid)7 uuringut
- Rinnavähk6 uuringut
- Skisofreenia5 uuringut
- Metastaatiline vähk5 uuringut
- Eesnäärmevähk5 uuringut
- Munasarjavähk5 uuringut
- Suur depressiivne häire5 uuringut
- Depressioon5 uuringut
- Äge müeloidne leukeemia5 uuringut
- Uroteeliaalne (ülemineku-rakkude) kartsinoom4 uuringut
- Põievähk4 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.